The effect of inactivated lactobacillus LB fermented culture medium on symptom severity: Observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome

Digestive Diseases

Volumn 29, Issue 6, 2011, Pages 588-591

  Tarrerias, A L ^a   Costil, V ^a   Vicari, F ^a   Letard J C ^a   Adenis Lamarre, P ^a   Aisene A ^a   Batistelli, D ^a   Bonnaud, G ^a   Carpentier, S ^a   Dalbies P ^a   Ecuer, S ^a   Etienne, J ^a   Fantoli, M ^a   Grunberg, B ^a   Lannoy, P ^a   Lapuelle, J ^a   Margulies, A ^a   Neumeier, M ^a   Rouillon, J M ^a   Schmets, L ^a   Pingannaud, M P ^a   Coulom, P ^a   Kholer, F ^a   Canard, J M ^a   more..

^a HÔTEL DIEU   (France)

Author keywords

Diarrhea; Health related quality of life; Irritable bowel syndrome; Microflora; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIUM CULTURE; BLOATING; CHI SQUARE TEST; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIARRHEA; DIETARY INTAKE; FAT INTAKE; FECES ANALYSIS; FECES INCONTINENCE; FERMENTATION MEDIUM; FOOD INTAKE; FRUIT; FUNCTIONAL ASSESSMENT; HUMAN; IRRITABLE COLON; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS FERMENTUM; LIQUID FECES; MAJOR CLINICAL STUDY; MILK; PEPPER; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; SPICE; VEGETABLE; VISUAL ANALOG SCALE;

CALCIUM CARBONATE; CULTURE MEDIA; DIARRHEA; DRUG COMBINATIONS; FECES; FERMENTATION; HUMANS; IRRITABLE BOWEL SYNDROME; LACTOBACILLUS; LACTOSE; MICROBIAL VIABILITY; MIDDLE AGED; QUESTIONNAIRES;

EID: 84055200081     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000332987     Document Type: Article

References (13)

1. Jones R, Lydeard S: Irritable bowel syndrome in the general population. BMJ 1992; 304: 87-90.
2. Longstreth GF, Wolde-Tsadi KG: Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig Dis Sci 1993; 38: 1581-1589. (Pubitemid 23271410)
3. Osman N, Adawi D, Ahrné S, Jeppsson B, Molin G: Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)- induced colitis. Dig Dis Sci 2008; 53: 2464-2473.
4. Dainese R, Galliani EA, De Lazzari F, Di Leo V, Naccarato R: Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999; 94: 1892-1897. (Pubitemid 29315906)
5. Dapoigny M, Stockbrügger RW, Azpiroz F, Collins S, Coremans G, Müller-Lissner S, Oberndorff A, Pace F, Smout A, Vatn M, Whorwell P: Role of alimentation in irritable bowel syndrome. Digestion 2003; 67: 225-233. (Pubitemid 37100203)
6. Parés D, Vial M, Bohle B, Maestre Y, Pera M, Roura M, Comas M, Sala M, Grande L: Prevalence of fecal incontinence and analysis of its impact on quality of life and mental health. Colorectal Dis 2011; 13: 899-905.
7. Lee V, Guthrie E, Robinson A, Kennedy A, Tomenson B, Rogers A, Thompson D: Functional bowel disorders in primary care: Factors associated with health-related quality of life and doctor consultation. J Psychosom Res 2008; 64: 129-138.
8. Minocha A, Johnson WD, Abell TL, Wigington WC: Prevalence, sociodemography, and quality of life of older versus younger patients with irritable bowel syndrome: A population- based study. Dig Dis Sci 2006; 51: 446-453.
9. Agrawal A, Houghton LA, Reilly B, Morris J, Whorwell PJ: Bloating and distension in irritable bowel syndrome: The role of gastrointestinal transit. Am J Gastroenterol 2009; 104: 1998-2004.
10. Park JH, Rhee PL, Kim G, Lee JH, Kim YH, Kim JJ, Rhee JC, Song SY: Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2006; 18: 539-549.
11. Coconnier MH, Lievin V, Bernet-Canard MF, Hudault S, Servin AL: Antibacterial effect of adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 1997; 41: 1046-1052. (Pubitemid 27194183)
12. Xiao SD, Zhang DZ, Lu H, Jiang SH, Liu HY, Wang GS, Xu GM, Zhang ZB, Lin GJ, Wang GL: Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther 2003; 20: 253-260. (Pubitemid 38101668)
13. Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME: Treatment of irritable bowel syndrome with Lacteol Fort: A randomized, double-blind, cross-over trial. Am J Gastroenterol 1996; 91: 1579-1585. (Pubitemid 26269174)